Lisa Sarfaty: Exploring and addressing inequities in rare diseases
Rare diseases can present numerous challenges for those living with these conditions and the healthcare professionals caring for them. In this interview we discuss some of these with Lisa Sarfaty, VP of Communication and Engagement for NORD (The National Organization for Rare Disorders) and explore ways in which they could be tackled.
- Could you tell us a little about the inequities surrounding living with a rare condition? (0:18)
- What systemic changes do you think are needed to address these and generate change? (3:02)
We hope that this conversation can continue our work to help support the rare disease community, increase awareness and improve understanding.
Disclosures: Lisa Sarfaty has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Gina Furnival.
Share this Video
Related Videos In Policy
Helena Ullgren: PrEvCan | Focus on alcohol and cancer prevention
The European Code Against Cancer (ECAC) recommends that if you drink alcohol of any type you should limit your intake and that not drinking alcohol is best for cancer prevention. This March, the PrEvCan campaign, spearheaded by EONS to promote cancer prevention across Europe, is bringing attention to the link between alcohol consumption and cancer […]
Pompiliu Piso: ESSO Oncopolicy – cross-multidisciplinary training in oncology at the EU level (Part 2)
The European Society of Surgical Oncology (ESSO), along with other cancer-related European societies, supported the proposal for cross-multidisciplinary training in oncology at the EU level. It was a pleasure to talk with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, Regensburg, Germany) to discuss how cross-multidisciplinary training would affect cancer care in Europe and the other initiatives […]
Pompiliu Piso: ESSO’s open letter recognizing surgical oncology as a specialist discipline in the EU (Part 1)
The European Society of Surgical Oncology (ESSO) recently released an open letter urging the European Commission to recognise surgical oncology as a specialist discipline in the EU, entitled ‘Time to act: Maximizing the benefits of surgical oncology for cancer patients in Europe‘. touchONCOLOGY were delighted to catch up with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!